Y.D. More Investments Ltd Reduces Stock Position in Amdocs Limited $DOX

Y.D. More Investments Ltd lowered its holdings in Amdocs Limited (NASDAQ:DOX) by 46.5% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 4,115 shares of the technology company’s stock after selling 3,570 shares during the quarter. Y.D. More Investments Ltd’s holdings in Amdocs were worth $375,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Pzena Investment Management LLC increased its stake in Amdocs by 2.1% in the second quarter. Pzena Investment Management LLC now owns 6,551,065 shares of the technology company’s stock valued at $597,719,000 after purchasing an additional 132,463 shares during the last quarter. LSV Asset Management boosted its holdings in shares of Amdocs by 11.1% in the 1st quarter. LSV Asset Management now owns 3,180,501 shares of the technology company’s stock valued at $291,016,000 after buying an additional 317,412 shares in the last quarter. Alyeska Investment Group L.P. grew its position in shares of Amdocs by 38.6% in the 1st quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company’s stock valued at $213,174,000 after buying an additional 648,693 shares during the last quarter. American Century Companies Inc. raised its stake in Amdocs by 23.5% during the 1st quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company’s stock worth $205,219,000 after acquiring an additional 426,911 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in Amdocs by 9.4% in the first quarter. Dimensional Fund Advisors LP now owns 2,120,075 shares of the technology company’s stock valued at $193,978,000 after acquiring an additional 182,489 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Stock Performance

DOX traded down $0.73 during trading on Monday, reaching $77.02. The company’s stock had a trading volume of 63,979 shares, compared to its average volume of 780,234. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.22 and a current ratio of 1.22. The company’s fifty day moving average price is $83.02 and its 200-day moving average price is $87.26. Amdocs Limited has a 52-week low of $75.35 and a 52-week high of $95.41. The company has a market capitalization of $8.69 billion, a price-to-earnings ratio of 15.61, a price-to-earnings-growth ratio of 1.40 and a beta of 0.51.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings results on Tuesday, November 11th. The technology company reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.82 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same period in the previous year, the business earned $1.70 earnings per share. The company’s revenue for the quarter was down 9.0% compared to the same quarter last year. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS. Q1 2026 guidance at 1.730-1.790 EPS. On average, equities analysts forecast that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be given a $0.527 dividend. The ex-dividend date is Wednesday, December 31st. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.7%. Amdocs’s dividend payout ratio (DPR) is currently 41.58%.

Analysts Set New Price Targets

A number of analysts have recently commented on DOX shares. Wall Street Zen cut Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Bank of America decreased their price objective on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday, November 12th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a report on Thursday, October 30th. Wolfe Research reiterated a “peer perform” rating on shares of Amdocs in a research report on Thursday. Finally, Stifel Nicolaus lowered their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research report on Wednesday, November 12th. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $97.00.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.